Trial ID or NCT#

NCT00238576

Status

not recruiting iconNOT RECRUITING

Purpose

This project will expand current knowledge of reproductive biology in women with bipolar disorder as well as assessing the impact of lamotrigine use for the treatment of bipolar disorder on reproductive function. Specifically, this study examines mood over the menstrual cycle and ovulation for three consecutive menstrual cycles in women treated for bipolar I, II, or NOS (not otherwise specified) with lamotrigine. In addition, testosterone and lipid concentrations will be measured before the participant starts receiving lamotrigine, as well as six months after receiving lamotrigine.

Official Title

Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age

Eligibility Criteria

Ages Eligible for Study: 18 Years to 45 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No

Investigator(s)

Natalie L. Rasgon
Natalie L. Rasgon
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) at the Stanford University Medical Center, Emerita

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM